Top Markets
Coin of the day
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Peringkat dalam Saham #31074
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Harga Saham
$0.404
Kapitalisasi Pasar
$14.28M
Perubahan (1 hari)
-10.42%
Perubahan (1 tahun)
-67.68%
Negara
IL
Perdagangan NeuroSense Therapeutics Ltd. (NRSN)

Kategori

Riwayat harga saham NeuroSense Therapeutics Ltd. (NRSN)
Harga penutupan tertinggi: $0.47 pada 2026-08-01

Harga penutupan terendah: $3.04 pada 2021-12-01
Riwayat harga saham NeuroSense Therapeutics Ltd. dari 2021 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) -1.04%
2025 -17.69%
2024 31.68%
2023 -42.23%
2022 -51.82%
2021 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$528.88 35.65%
US
$1.00K 51.38%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE